In contrast, angina patients show increased platelet expression of CXCL12, compared to healthy controls, and plasma CXCL12 levels correlate with platelet activation, suggesting more pro-atherogenic effects of CXCL12 [75]. This evidence concerns the gene CXCL12 and angina pectoris.